Joseph K. Belanoff, Chief Executive Officer, 10% Owner at CORCEPT THERAPEUTICS INC (CORT), sold 5,000 shares at $0.86 ($4K) on 2006-09-29, disclosed to the SEC on 2006-10-03.
Scheduled sale ($4k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |